---
figid: PMC6281417__oncotarget-09-36151-g007
figlink: /pmc/articles/PMC6281417/figure/F7/
number: F7
caption: Schematic representation of the inhibitory effect of HLSC-EVs and of TKIs
  alone or in combination on PI3K pathway and Erk. In particular, the co-administration
  of HLSC-EVs/TKIs exerted a synergistic effect (orange bars) on the inhibition of
  Akt and mTOR pathways and on pPTEN. HLSC-EVs alone (red bars) showed an inhibitory
  effect on Akt, mTOR pathways and on transcription factor Creb. Sunitinib or Sorafenib
  alone (yellow bars) inhibit RAS and mTOR pathways.
pmcid: PMC6281417
papertitle: Human liver stem cell-derived extracellular vesicles enhance cancer stem
  cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation.
reftext: Valentina Fonsato, et al. Oncotarget. 2018 Nov 16;9(90):36151-36165.
pmc_ranked_result_index: '143331'
pathway_score: 0.9639532
filename: oncotarget-09-36151-g007.jpg
figtitle: Human liver stem cell-derived extracellular vesicles enhance cancer stem
  cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation
year: '2018'
organisms:
- Mus musculus
- Homo sapiens
- Bos taurus
- Capra hircus
- Oryctolagus cuniculus
ndex: 36e709ea-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6281417__oncotarget-09-36151-g007.html
  '@type': Dataset
  description: Schematic representation of the inhibitory effect of HLSC-EVs and of
    TKIs alone or in combination on PI3K pathway and Erk. In particular, the co-administration
    of HLSC-EVs/TKIs exerted a synergistic effect (orange bars) on the inhibition
    of Akt and mTOR pathways and on pPTEN. HLSC-EVs alone (red bars) showed an inhibitory
    effect on Akt, mTOR pathways and on transcription factor Creb. Sunitinib or Sorafenib
    alone (yellow bars) inhibit RAS and mTOR pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATF1
  - NRAS
  - ATF2
  - CREB3L1
  - CREB3
  - CREB1
  - CREM
  - MTOR
  - CREB3L4
  - ARAF
  - MAP2K2
  - BRAF
  - HRAS
  - KRAS
  - RAF1
  - AKT2
  - AKT1
  - AKT3
  - MAPK1
  - MAPK3
  - MAP2K1
  - PTEN
  - CREB5
  - CREB3L2
  - CREB3L3
  - Sunitinib
  - Sorafenib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: Creb
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
chemicals:
- word: Sunitinib
  source: MESH
  identifier: C473478
- word: Sorafenib
  source: MESH
  identifier: C471405
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC6281417__F7
redirect_from: /figures/PMC6281417__F7
figtype: Figure
---
